Biomarker discovery for disease progression and metastasis in prostate cancer: a multi-omic approach

Tools

Wagner, S. ORCID: 0000-0002-5221-9851, 2019. Biomarker discovery for disease progression and metastasis in prostate cancer: a multi-omic approach. PhD, Nottingham Trent University.

Preview

Text
Sarah Wagner 2019 excl3rdpartycopyright.pdf - Published version
Download (13MB) | Preview

Abstract

Prostate cancer (PCa) is the most common cancer in men and the third most common cause of cancer-related deaths in Europe, which is primarily due to the development of metastasis, which decreases the 5-year survival rate to 30 %. The development of metastasis is the major cause of death in cancer patients and the process highly implicated in the ability of cancer cells to spread is called epithelial to mesenchymal transition (EMT). The aim of this study was to use inducible in vitro EMT models for the discovery of novel disease associated biomarkers through the use of multi-omics datasets.

For this, two PCa cell lines were stimulated with transforming growth factor β (TGF-β), resulting in apparent morphological changes indicating a cellular change in the direction of an increased mesenchymal morphology. Induction of EMT was confirmed using quantitative real-time PCR, immunofluorescence staining and western blot analysis. To improve the understanding of underlying changes and for the discovery of novel biomarkers, proteomic and transcriptomic profiles of both models in their induced and non-induced states were generated. Their subsequent integration highlighted 13 potential biomarkers indicative for the process of EMT in PCa and metastasis development. Out of the 13 core markers, four of these were taken forward and further validated using tissue microarrays and the in silico analysis of publicly available datasets. The generated results have supported the association of all 4 markers with EMT and disease progression, however two markers were identified to be of particular interest (DPYL3 and SDPR). These two markers have shown significant differences between primary PCa and castration-resistant prostate cancer (CRPC) and Gleason scoring. Furthermore, both of them were shown to be predictive for disease-recurrence. Overall, the generated results have highlighted the successful application of an integrated omics approach for the discovery of novel disease-associated biomarkers for PCa progression.

Item Type:	Thesis
Creators:	Wagner, S.
Date:	February 2019
Rights:	This work is the intellectual property of the author. You may copy up to 5% of this work for private study, or personal, non-commercial research. Any re-use of the information contained within this document should be fully referenced, quoting the author, title, university, degree level and pagination. Queries or requests for any other use, or if a more substantial copy is required, should be directed to the owner(s) of the Intellectual Property Rights.
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	18 Sep 2019 08:39
Last Modified:	07 Feb 2022 14:59
URI:	https://irep.ntu.ac.uk/id/eprint/37687